- Home
- LTM vs QGEN Comparison
LTM vs QGEN Comparison
Compare LTM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTM
- QGEN
- Stock Information
- Founded
- LTM 1929
- QGEN 1986
- Country
- LTM Chile
- QGEN Netherlands
- Employees
- LTM N/A
- QGEN N/A
- Industry
- LTM
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTM
- QGEN Health Care
- Exchange
- LTM NYSE
- QGEN Nasdaq
- Market Cap
- LTM 8.9B
- QGEN 9.1B
- IPO Year
- LTM N/A
- QGEN 1996
- Fundamental
- Price
- LTM $30.46
- QGEN $42.10
- Analyst Decision
- LTM Strong Buy
- QGEN Buy
- Analyst Count
- LTM 3
- QGEN 9
- Target Price
- LTM $38.00
- QGEN $49.93
- AVG Volume (30 Days)
- LTM 378.2K
- QGEN 1.6M
- Earning Date
- LTM 01-01-0001
- QGEN 05-07-2025
- Dividend Yield
- LTM 3.52%
- QGEN 3.06%
- EPS Growth
- LTM 67.98
- QGEN N/A
- EPS
- LTM 0.00
- QGEN 0.38
- Revenue
- LTM $12,833,043,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- LTM $9.30
- QGEN $4.74
- Revenue Next Year
- LTM $4.48
- QGEN $6.52
- P/E Ratio
- LTM $9.38
- QGEN $113.14
- Revenue Growth
- LTM 10.24
- QGEN 0.66
- 52 Week Low
- LTM $21.83
- QGEN $37.63
- 52 Week High
- LTM $33.50
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- LTM N/A
- QGEN 55.63
- Support Level
- LTM N/A
- QGEN $40.00
- Resistance Level
- LTM N/A
- QGEN $43.13
- Average True Range (ATR)
- LTM 0.00
- QGEN 1.40
- MACD
- LTM 0.00
- QGEN 0.20
- Stochastic Oscillator
- LTM 0.00
- QGEN 66.42
About LTM LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS
LATAM Airlines Group SA operates as a passenger airline group. The company and its affiliates provide domestic services in Brazil, Chile, Peru, Colombia, and Ecuador, as well as regional flights and long-haul operations. LATAM group carries out cargo operations using both belly space on passenger flights and dedicated freighter aircraft. In addition, it also offers complementary services, such as ground handling, courier, logistics, and maintenance. Geographically, the group generates maximum revenue from Brazil, followed by Chile, the United States of America, Peru, Europe, Colombia, Ecuador, Asia Pacific, and the rest of Latin America.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).